122 P16 Immunohistochemistry Use in the Classification of Cervical Biopsies: Assessing Pathology Trainees’ Diagnostic Proficiency

Abstract Objectives In 2013, the nomenclature for human papillomavirus (HPV)-related lower anogenital squamous lesions was updated to a two-tiered system: high-grade squamous intraepithelial lesion (HSIL) vs low-grade squamous intraepithelial lesion (LSIL). LSIL represents transient HPV infection (C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of clinical pathology 2018-01, Vol.149 (suppl_1), p.S52-S53
Hauptverfasser: Sultan, Kieran, Liu, Yuxin, Kalir, Tamara
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S53
container_issue suppl_1
container_start_page S52
container_title American journal of clinical pathology
container_volume 149
creator Sultan, Kieran
Liu, Yuxin
Kalir, Tamara
description Abstract Objectives In 2013, the nomenclature for human papillomavirus (HPV)-related lower anogenital squamous lesions was updated to a two-tiered system: high-grade squamous intraepithelial lesion (HSIL) vs low-grade squamous intraepithelial lesion (LSIL). LSIL represents transient HPV infection (CIN1); HSIL represents true cancer precursors (formerly CIN2/3). P16 immunohistochemistry (IHC) plays a critical role in the implementation of this new terminology. However, difficulties arise both in its judicious use and interpretation. Concerning p16 IHC use in grading cervical HPV-related lesions, we set out to determine pathology trainees’ proficiency and interpretive skills with a goal of developing targeted, efficient training. Methods Twelve pathology residents (PGY 2–5) participated in a survey of 20 cervical biopsies that included five unequivocal CIN1, five unequivocal CIN3, and 10 intermediate lesions (CIN2). We recorded trainees’ initial H&E diagnosis (CIN1, CIN3, CIN2 requiring p16), frequency of p16 use, p16 interpretation (positive vs negative), and the final diagnosis (LSIL or HSIL) based on combined H&E and p16. Results Based on H&E morphology, participants’ initial diagnostic accuracy was 98% (59/60) for unequivocal CIN3 lesions, 72% (43/60) for unequivocal CIN1 lesions, and 57% (68/120) for CIN2 lesions. P16 IHC was required for an average of 48% of cases (range 30%-65%). Participants correctly interpreted 91% (42/46) of block-positive p16 patterns, 50% (5/10) of negative patterns, and 40% (28/69) of non-block positive patterns including weak/diffuse, strong/focal, and strong/basal stainings. Based on combined H&E and p16 IHC, participants’ final diagnostic accuracy was 86% for HSIL and 72% for LSIL. Conclusion Pathology trainees are up-to-date regarding current terminology and p16 applications. They are proficient in diagnosing unequivocal high-grade and low-grade lesions based on H&E morphology as well as interpreting block-positive p16 results. However, their skill deficiencies lie in handling morphologically intermediate lesions and interpreting non-block p16 staining patterns. We recommend enhanced training targeting these deficiencies.
doi_str_mv 10.1093/ajcp/aqx118.121
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2363912807</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ajcp/aqx118.121</oup_id><sourcerecordid>2363912807</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1441-ee266d6112534e41deef9d322097ab6a5fffb73474009f0b97c0ce0929190d023</originalsourceid><addsrcrecordid>eNqFkM1OAjEUhRujiYiu3TZxZzJwbzvMUHeKfyQksoD1pJRbKIHp0A5GdiY-ha_nkzgE965ObvKdc5OPsWuEDoKSXb0yVVdvPxD7HRR4wlqoUpnkuRCnrAUAIlGYy3N2EeMKAEUf0hb7QiH4GDM-3Gx2pV-6WHuzpE2TYc-nkbgreb0kPljrGJ11RtfOl9xbPqDw3pxr_uB8FR3FO34fIzVUueBjXS_92i_2fBK0K4niz-c3f3R6UfpYO8PHwTdjjkqzv2RnVq8jXf1lm02fnyaD12T09jIc3I8Sg2mKCZHIsnmGKHoypRTnRFbNpRCgcj3LdM9aO8tlmqcAysJM5QYMgRIKFcxByDa7Oe5WwW93FOti5XehbF4WQmZSHZTkDdU9Uib4GAPZogpuo8O-QCgOpouD6eJoumhMN43bY8Pvqn_hX3I5gok</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2363912807</pqid></control><display><type>article</type><title>122 P16 Immunohistochemistry Use in the Classification of Cervical Biopsies: Assessing Pathology Trainees’ Diagnostic Proficiency</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Sultan, Kieran ; Liu, Yuxin ; Kalir, Tamara</creator><creatorcontrib>Sultan, Kieran ; Liu, Yuxin ; Kalir, Tamara</creatorcontrib><description>Abstract Objectives In 2013, the nomenclature for human papillomavirus (HPV)-related lower anogenital squamous lesions was updated to a two-tiered system: high-grade squamous intraepithelial lesion (HSIL) vs low-grade squamous intraepithelial lesion (LSIL). LSIL represents transient HPV infection (CIN1); HSIL represents true cancer precursors (formerly CIN2/3). P16 immunohistochemistry (IHC) plays a critical role in the implementation of this new terminology. However, difficulties arise both in its judicious use and interpretation. Concerning p16 IHC use in grading cervical HPV-related lesions, we set out to determine pathology trainees’ proficiency and interpretive skills with a goal of developing targeted, efficient training. Methods Twelve pathology residents (PGY 2–5) participated in a survey of 20 cervical biopsies that included five unequivocal CIN1, five unequivocal CIN3, and 10 intermediate lesions (CIN2). We recorded trainees’ initial H&amp;E diagnosis (CIN1, CIN3, CIN2 requiring p16), frequency of p16 use, p16 interpretation (positive vs negative), and the final diagnosis (LSIL or HSIL) based on combined H&amp;E and p16. Results Based on H&amp;E morphology, participants’ initial diagnostic accuracy was 98% (59/60) for unequivocal CIN3 lesions, 72% (43/60) for unequivocal CIN1 lesions, and 57% (68/120) for CIN2 lesions. P16 IHC was required for an average of 48% of cases (range 30%-65%). Participants correctly interpreted 91% (42/46) of block-positive p16 patterns, 50% (5/10) of negative patterns, and 40% (28/69) of non-block positive patterns including weak/diffuse, strong/focal, and strong/basal stainings. Based on combined H&amp;E and p16 IHC, participants’ final diagnostic accuracy was 86% for HSIL and 72% for LSIL. Conclusion Pathology trainees are up-to-date regarding current terminology and p16 applications. They are proficient in diagnosing unequivocal high-grade and low-grade lesions based on H&amp;E morphology as well as interpreting block-positive p16 results. However, their skill deficiencies lie in handling morphologically intermediate lesions and interpreting non-block p16 staining patterns. We recommend enhanced training targeting these deficiencies.</description><identifier>ISSN: 0002-9173</identifier><identifier>EISSN: 1943-7722</identifier><identifier>DOI: 10.1093/ajcp/aqx118.121</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Anogenital ; Biopsy ; Cervix ; Diagnosis ; Human papillomavirus ; Immunohistochemistry ; Lesions ; Medical diagnosis ; Morphology ; Nomenclature ; Pathology ; Terminology</subject><ispartof>American journal of clinical pathology, 2018-01, Vol.149 (suppl_1), p.S52-S53</ispartof><rights>American Society for Clinical Pathology, 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018</rights><rights>American Society for Clinical Pathology, 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids></links><search><creatorcontrib>Sultan, Kieran</creatorcontrib><creatorcontrib>Liu, Yuxin</creatorcontrib><creatorcontrib>Kalir, Tamara</creatorcontrib><title>122 P16 Immunohistochemistry Use in the Classification of Cervical Biopsies: Assessing Pathology Trainees’ Diagnostic Proficiency</title><title>American journal of clinical pathology</title><description>Abstract Objectives In 2013, the nomenclature for human papillomavirus (HPV)-related lower anogenital squamous lesions was updated to a two-tiered system: high-grade squamous intraepithelial lesion (HSIL) vs low-grade squamous intraepithelial lesion (LSIL). LSIL represents transient HPV infection (CIN1); HSIL represents true cancer precursors (formerly CIN2/3). P16 immunohistochemistry (IHC) plays a critical role in the implementation of this new terminology. However, difficulties arise both in its judicious use and interpretation. Concerning p16 IHC use in grading cervical HPV-related lesions, we set out to determine pathology trainees’ proficiency and interpretive skills with a goal of developing targeted, efficient training. Methods Twelve pathology residents (PGY 2–5) participated in a survey of 20 cervical biopsies that included five unequivocal CIN1, five unequivocal CIN3, and 10 intermediate lesions (CIN2). We recorded trainees’ initial H&amp;E diagnosis (CIN1, CIN3, CIN2 requiring p16), frequency of p16 use, p16 interpretation (positive vs negative), and the final diagnosis (LSIL or HSIL) based on combined H&amp;E and p16. Results Based on H&amp;E morphology, participants’ initial diagnostic accuracy was 98% (59/60) for unequivocal CIN3 lesions, 72% (43/60) for unequivocal CIN1 lesions, and 57% (68/120) for CIN2 lesions. P16 IHC was required for an average of 48% of cases (range 30%-65%). Participants correctly interpreted 91% (42/46) of block-positive p16 patterns, 50% (5/10) of negative patterns, and 40% (28/69) of non-block positive patterns including weak/diffuse, strong/focal, and strong/basal stainings. Based on combined H&amp;E and p16 IHC, participants’ final diagnostic accuracy was 86% for HSIL and 72% for LSIL. Conclusion Pathology trainees are up-to-date regarding current terminology and p16 applications. They are proficient in diagnosing unequivocal high-grade and low-grade lesions based on H&amp;E morphology as well as interpreting block-positive p16 results. However, their skill deficiencies lie in handling morphologically intermediate lesions and interpreting non-block p16 staining patterns. We recommend enhanced training targeting these deficiencies.</description><subject>Anogenital</subject><subject>Biopsy</subject><subject>Cervix</subject><subject>Diagnosis</subject><subject>Human papillomavirus</subject><subject>Immunohistochemistry</subject><subject>Lesions</subject><subject>Medical diagnosis</subject><subject>Morphology</subject><subject>Nomenclature</subject><subject>Pathology</subject><subject>Terminology</subject><issn>0002-9173</issn><issn>1943-7722</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqFkM1OAjEUhRujiYiu3TZxZzJwbzvMUHeKfyQksoD1pJRbKIHp0A5GdiY-ha_nkzgE965ObvKdc5OPsWuEDoKSXb0yVVdvPxD7HRR4wlqoUpnkuRCnrAUAIlGYy3N2EeMKAEUf0hb7QiH4GDM-3Gx2pV-6WHuzpE2TYc-nkbgreb0kPljrGJ11RtfOl9xbPqDw3pxr_uB8FR3FO34fIzVUueBjXS_92i_2fBK0K4niz-c3f3R6UfpYO8PHwTdjjkqzv2RnVq8jXf1lm02fnyaD12T09jIc3I8Sg2mKCZHIsnmGKHoypRTnRFbNpRCgcj3LdM9aO8tlmqcAysJM5QYMgRIKFcxByDa7Oe5WwW93FOti5XehbF4WQmZSHZTkDdU9Uib4GAPZogpuo8O-QCgOpouD6eJoumhMN43bY8Pvqn_hX3I5gok</recordid><startdate>20180111</startdate><enddate>20180111</enddate><creator>Sultan, Kieran</creator><creator>Liu, Yuxin</creator><creator>Kalir, Tamara</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20180111</creationdate><title>122 P16 Immunohistochemistry Use in the Classification of Cervical Biopsies: Assessing Pathology Trainees’ Diagnostic Proficiency</title><author>Sultan, Kieran ; Liu, Yuxin ; Kalir, Tamara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1441-ee266d6112534e41deef9d322097ab6a5fffb73474009f0b97c0ce0929190d023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anogenital</topic><topic>Biopsy</topic><topic>Cervix</topic><topic>Diagnosis</topic><topic>Human papillomavirus</topic><topic>Immunohistochemistry</topic><topic>Lesions</topic><topic>Medical diagnosis</topic><topic>Morphology</topic><topic>Nomenclature</topic><topic>Pathology</topic><topic>Terminology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sultan, Kieran</creatorcontrib><creatorcontrib>Liu, Yuxin</creatorcontrib><creatorcontrib>Kalir, Tamara</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sultan, Kieran</au><au>Liu, Yuxin</au><au>Kalir, Tamara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>122 P16 Immunohistochemistry Use in the Classification of Cervical Biopsies: Assessing Pathology Trainees’ Diagnostic Proficiency</atitle><jtitle>American journal of clinical pathology</jtitle><date>2018-01-11</date><risdate>2018</risdate><volume>149</volume><issue>suppl_1</issue><spage>S52</spage><epage>S53</epage><pages>S52-S53</pages><issn>0002-9173</issn><eissn>1943-7722</eissn><abstract>Abstract Objectives In 2013, the nomenclature for human papillomavirus (HPV)-related lower anogenital squamous lesions was updated to a two-tiered system: high-grade squamous intraepithelial lesion (HSIL) vs low-grade squamous intraepithelial lesion (LSIL). LSIL represents transient HPV infection (CIN1); HSIL represents true cancer precursors (formerly CIN2/3). P16 immunohistochemistry (IHC) plays a critical role in the implementation of this new terminology. However, difficulties arise both in its judicious use and interpretation. Concerning p16 IHC use in grading cervical HPV-related lesions, we set out to determine pathology trainees’ proficiency and interpretive skills with a goal of developing targeted, efficient training. Methods Twelve pathology residents (PGY 2–5) participated in a survey of 20 cervical biopsies that included five unequivocal CIN1, five unequivocal CIN3, and 10 intermediate lesions (CIN2). We recorded trainees’ initial H&amp;E diagnosis (CIN1, CIN3, CIN2 requiring p16), frequency of p16 use, p16 interpretation (positive vs negative), and the final diagnosis (LSIL or HSIL) based on combined H&amp;E and p16. Results Based on H&amp;E morphology, participants’ initial diagnostic accuracy was 98% (59/60) for unequivocal CIN3 lesions, 72% (43/60) for unequivocal CIN1 lesions, and 57% (68/120) for CIN2 lesions. P16 IHC was required for an average of 48% of cases (range 30%-65%). Participants correctly interpreted 91% (42/46) of block-positive p16 patterns, 50% (5/10) of negative patterns, and 40% (28/69) of non-block positive patterns including weak/diffuse, strong/focal, and strong/basal stainings. Based on combined H&amp;E and p16 IHC, participants’ final diagnostic accuracy was 86% for HSIL and 72% for LSIL. Conclusion Pathology trainees are up-to-date regarding current terminology and p16 applications. They are proficient in diagnosing unequivocal high-grade and low-grade lesions based on H&amp;E morphology as well as interpreting block-positive p16 results. However, their skill deficiencies lie in handling morphologically intermediate lesions and interpreting non-block p16 staining patterns. We recommend enhanced training targeting these deficiencies.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/ajcp/aqx118.121</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9173
ispartof American journal of clinical pathology, 2018-01, Vol.149 (suppl_1), p.S52-S53
issn 0002-9173
1943-7722
language eng
recordid cdi_proquest_journals_2363912807
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Anogenital
Biopsy
Cervix
Diagnosis
Human papillomavirus
Immunohistochemistry
Lesions
Medical diagnosis
Morphology
Nomenclature
Pathology
Terminology
title 122 P16 Immunohistochemistry Use in the Classification of Cervical Biopsies: Assessing Pathology Trainees’ Diagnostic Proficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T08%3A24%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=122%20P16%20Immunohistochemistry%20Use%20in%20the%20Classification%20of%20Cervical%20Biopsies:%20Assessing%20Pathology%20Trainees%E2%80%99%20Diagnostic%20Proficiency&rft.jtitle=American%20journal%20of%20clinical%20pathology&rft.au=Sultan,%20Kieran&rft.date=2018-01-11&rft.volume=149&rft.issue=suppl_1&rft.spage=S52&rft.epage=S53&rft.pages=S52-S53&rft.issn=0002-9173&rft.eissn=1943-7722&rft_id=info:doi/10.1093/ajcp/aqx118.121&rft_dat=%3Cproquest_cross%3E2363912807%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2363912807&rft_id=info:pmid/&rft_oup_id=10.1093/ajcp/aqx118.121&rfr_iscdi=true